Most cited in @EurUrolFocus: “PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer” | Read here: https://t.co/WyundnOV7M #EAU18 https://t.co/sgQWGOgLbN
Most cited in @EurUrolFocus: “PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer” | Read here: https://t.co/WyundnOV7M #EAU18 https://t.co/sgQWGOgLbN